Dosimetric parameters and absolute monocyte count can predict the prognosis of acute hematologic toxicity in cervical cancer patients undergoing concurrent chemotherapy and volumetric-modulated arc therapy

PURPOSE: To explore clinical and dosimetric predictors of acute hematologic toxicity (HT) in cervical cancer patients treated with concurrent chemotherapy and volumetric-modulated arc therapy (VMAT). METHODS AND MATERIALS: We retrospectively reviewed the clinical data of 184 cervical cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Xiaoyong, Ding, Zhen, Zeng, Qi, Feng, Lingling, Qiu, Chunyan, Chen, Dongjie, Lu, Jiawei, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898435/
https://www.ncbi.nlm.nih.gov/pubmed/35248087
http://dx.doi.org/10.1186/s13014-022-02018-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898435/
https://www.ncbi.nlm.nih.gov/pubmed/35248087
http://dx.doi.org/10.1186/s13014-022-02018-1

Ejemplares similares